News and Analysis
Innovation, Technology, and IP News
Fresh From the Bench: Latest Federal Circuit Court Case
CASE OF THE WEEK Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., Appeal No. 2021-1070 (Fed. Cir. January 3, 2022) In this week’s Case of the Week, the...
Feed tagged as "biotechnology":
MODERNATX, INC. v. ARBUTUS BIOPHARMA CORPORATION
Before Lourie, O’Malley, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary... Read More »
MODERNATX, INC. v. ARBUTUS BIOPHARMA CORPORATION
Before Lourie, O’Malley and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary... Read More »
JUNO THERAPEUTICS, INC. v. KITE PHARMA, INC.
Before Moore, Prost, and O’Malley. Appeal from the United States District Court for the Central District of... Read More »
TEVA PHARMACEUTICALS v. ELI LILLY AND COMPANY
Before LOURIE, BRYSON, and O’MALLEY. Appeal from the Patent Trial and Appeal Board.
Summary: The... Read More »
PACIFIC BIOSCIENCES OF CALIFORNIA v. OXFORD NANOPORE TECHNOLOGIES
Before Lourie, Taranto, and Stoll. Appeal from the United States District Court for the... Read More »
MMUNEX CORPORATION v. SANOFI-AVENTIS U.S. LLC
Before Prost, Reyna, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: Expiration of a... Read More »
ILLUMINA, INC. v. ARIOSA DIAGNOSTICS, INC.
Before Lourie, Moore, and Reyna. Modified opinion following Ariosa rehearing petition.
Summary: The Federal Circuit ... Read More »
XY, LLC v. TRANS OVA GENETICS, LC
Before Wallach, Plager, and Stoll. Appeal from the United States District Court for the District of Colorado.
Summary: ... Read More »
CARDIONET, LLC v. INFOBIONIC, INC
Before Dyk, Plager, and Stoll. Dyk dissenting in part. Appeal from the District of Massachusetts.
Summary: Alice step one is ... Read More »
Written by: James Yang & Mark Kachner
NEVRO CORPORATION v. BOSTON SCIENTIFIC CORPORATION
Before Moore, Taranto, and Chen. Appeal from U.S. District Court... Read More »
ILLUMINA, INC. v. ARIOSA DIAGNOSTICS, INC.
Before Lourie, Moore, and Reyna. Appeal from the Northern District of California.
Summary: Use of a natural... Read More »
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH v. ANDREI IANCU, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND ... Read More »
Ajinomoto Co., Inc. vs. CH Cheiljedang Corp. (2018-1590, 2018-1629)
In a pair of cross-appeals from the International Trade Commission, the Federal Circuit... Read More »
QUAKE v. LO
Before Reyna, Chen, and Hughes. Appeal from the Patent Trial and Appeal Board (“PTAB”).
Summary: A claimed method must be... Read More »
ENZO LIFE SCIENCES, INC. v. ROCHE MOLECULAR SYSTEMS, INC.
Before Prost, Reyna, and Wallach. Appeal from the United States District Court for the... Read More »
A new bill introduced in Congress last week may limit the ability of branded pharmaceutical companies to extend the period of exclusivity products beyond the term of... Read More »
On April 1, 2019, the Federal Circuit issued a non-precedential decision in Cleveland Clinic Foundation, Cleveland HeartLab, Inc. v. True Health Diagnostics LLC... Read More »
In Natural Alternatives International, Inc. v. Creative Compounds, LLC., Appeal No. 2018-1295, a divided panel of the Federal Circuit reversed and remanded ... Read More »
On March 7, 2019, the U.S. Food and Drug Administration (FDA) and the U.S. Food Safety and Inspection Service (FSIS) announced a formal agreement, in the form of a... Read More »
On February 6, 2019, the Federal Circuit decided Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, affirming a District Court for the District of... Read More »
